These results indicate that CJP–TiN+L treatment effectively enhanced immune activation in the tumor microenvironment, reduced the infiltration of immunosuppressive cells, and increased CD8+ T cell infiltration, which may enhance the antitumor immune response and provide immunological support for effectively inhibiting tumor growth. This evidence concerns the gene CD8A and neoplasm.